[Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Târgu Mureș, Romania].

The motor and non-motor complications of Parkinson's disease impair the patients' quality of life and limit therapeutical options. There are no clear criteria for 'advanced' Parkinson's disease or for the optimal moment for invasive therapies. There is little evidence regarding the upper limits of levodopa doses, and how these may be influenced by the availability of device-aided therapies.

[Gastrointestinal disorders caused by non-agglutinable (NAG) vibrios].

In August-October 1973 several NAG vibrio strains were isolated for the first time in our country from clinical cases of acute intestinal disturbances. The patients were admitted to hospital being clinically suspect of dysenteric syndrome or alimentary toxiinfection (nausea, vomiting, abdominal colics, tenesms, mucosanguinolent stools, aqeous stools from 4-5 up to 20 in 24 hours, with signs of dehydration). NAG vibrios were isolated from all the cultures in, practically, pure cultures.